Peter J. Weiden

 

 

 

 

 

 

 

Read a study examining the efficacy and tolerability of the long-acting injectable (LAI) aripiprazole lauroxil from inpatient into follow-up outpatient care.

What are the primary causes of poor patient outcomes in psychiatry, and what can be done to address these? A panel of 58 experts in psychiatry completed a survey...

 

 

Long-acting injectable (LAI) antipsychotics improve adherence, reduce treatment gaps, and improve clinical outcomes. This report describes the long-term safety, tolerability, and symptom trajectory with the LAI antipsychotic aripiprazole lauroxil.

 

Explore an analysis on Mid-Term and Long-Term Efficacy and Effectiveness of Antipsychotic Medications for Schizophrenia.

 

 

 

 

 

Read the results on whether a longer half-life is associated with longer time to relapse after antipsychotic discontinuation, even among LAI formulations.

 

 

 

 

 

 

Injectable antipsychotics can help address the problem of nonadherence, which can lead to relapse. This study looks at the efficacy of the injectable antipsychotic aripiprazole lauroxil in achieving and...